The University of Chicago Header Logo

Connection

Jessica Donington to Aged, 80 and over

Back to Details
This is a "connection" page, showing publications Jessica Donington has written about Aged, 80 and over.
Jessica Donington
Connection Strength
0.502
Aged, 80 and over
  1. Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Jul; 25(5):440-448.
    View in: PubMed
    Score: 0.108
  2. Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy. J Thorac Cardiovasc Surg. 2024 Oct; 168(4):1261-1269.e1.
    View in: PubMed
    Score: 0.106
  3. Plasma osteopontin velocity differentiates lung cancers from controls in a CT screening population. Cancer Biomark. 2012; 12(4):177-84.
    View in: PubMed
    Score: 0.046
  4. Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer. J Clin Oncol. 2010 Feb 20; 28(6):936-41.
    View in: PubMed
    Score: 0.041
  5. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J Thorac Oncol. 2006 Oct; 1(8):802-9.
    View in: PubMed
    Score: 0.032
  6. Tumor response to induction chemoradiation: influence on survival after esophagectomy. Eur J Cardiothorac Surg. 2003 Oct; 24(4):631-6; discussion 636-7.
    View in: PubMed
    Score: 0.026
  7. Subsequent pulmonary resection for bronchogenic carcinoma after pneumonectomy. Ann Thorac Surg. 2002 Jul; 74(1):154-8; discussion 158-9.
    View in: PubMed
    Score: 0.024
  8. CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer. Sci Rep. 2021 10 08; 11(1):20059.
    View in: PubMed
    Score: 0.023
  9. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma. J Thorac Oncol. 2016 06; 11(6):900-9.
    View in: PubMed
    Score: 0.015
  10. Results from a single institution phase II trial of concurrent docetaxel/carboplatin/radiotherapy followed by surgical resection and consolidation docetaxel/carboplatin in stage III non-small-cell lung cancer. Clin Lung Cancer. 2011 Sep; 12(5):280-5.
    View in: PubMed
    Score: 0.011
  11. Tumor volume as a potential imaging-based risk-stratification factor in trimodality therapy for locally advanced non-small cell lung cancer. J Thorac Oncol. 2011 May; 6(5):920-6.
    View in: PubMed
    Score: 0.011
  12. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population. J Thorac Oncol. 2010 Oct; 5(10):1649-54.
    View in: PubMed
    Score: 0.011
  13. hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res. 2010 Mar 01; 70(5):1916-24.
    View in: PubMed
    Score: 0.010
  14. Initial experience with endobronchial ultrasound in an academic thoracic surgery program. Clin Lung Cancer. 2010 Jan; 11(1):25-9.
    View in: PubMed
    Score: 0.010
  15. Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
    View in: PubMed
    Score: 0.009
  16. Metabolic tumor burden predicts for disease progression and death in lung cancer. Int J Radiat Oncol Biol Phys. 2007 Oct 01; 69(2):328-33.
    View in: PubMed
    Score: 0.009
  17. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Clin Cancer Res. 2006 Mar 01; 12(5):1507-14.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.